SCHEMBL17675181

SCHEMBL17675181

C=CC(=O)Nc1ccc2nccc(Oc3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c2c1

nearest known ligand 0.75

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EGFR P00533 12/20 0.75
BTK Q06187 11/20 0.75
ERBB2 P04626 2/20 0.73
TEC P42680 1/20 0.73
TXK P42681 1/20 0.73
BLK P51451 1/20 0.73
BMX P51813 1/20 0.73
JAK3 P52333 1/20 0.73
ERBB4 Q15303 1/20 0.73
KDR P35968 5/20 0.51
BRAF P15056 3/20 0.51
MAPK14 Q16539 2/20 0.51
TNNI3K Q59H18 2/20 0.51
FGFR1 P11362 1/20 0.47
GRM5 P41594 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17675591 0.89 EGFR (0.79) EGFRBTKERBB2TECTXK
SCHEMBL17675352 0.88 EGFR (0.74) EGFRBTKERBB2TECTXK
SCHEMBL17675479 0.87 EGFR (0.79) EGFRBTKERBB2TECTXK
SCHEMBL17675514 0.86 BTK (0.78) EGFRBTKERBB2TECTXK
SCHEMBL17675364 0.86 BTK (1.00) EGFRBTKERBB2TECTXK
SCHEMBL17675400 0.85 EGFR (0.76) EGFRBTKERBB2TECTXK
SCHEMBL17683708 0.85 BTK (0.76) EGFRBTKERBB2TECTXK
Trifluoroacetic Acid SCHEMBL17675212 0.85 EGFR (0.89) EGFRBTKERBB2TECTXK
SCHEMBL17675390 0.84 EGFR (1.00) EGFRBTKERBB2TECTXK
SCHEMBL17675241 0.84 EGFR (0.67) EGFRBTKERBB2TECTXK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016055982-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS ACERTA PHARMA B.V. (NL) 2016-04-14 WO claimed
WO-2016055982-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS ACERTA PHARMA B.V. (NL) 2016-04-14 WO disclosed
WO-2016055982-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS ACERTA PHARMA B.V. (NL) 2016-04-14 WO disclosed